Lewis Clayton Cantley Jr., Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 9,704 shares at $61.10 ($593K) on 2015-10-23, disclosed to the SEC on 2015-10-27.
Scheduled sale ($593k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.21 | 2,426 | $148K | 25.0% |
| 2 | $61.22 | 2,426 | $149K | 25.0% |
| 3 | $61.10 | 2,426 | $148K | 25.0% |
| 4 | $61.11 | 2,426 | $148K | 25.0% |
| Total | $61.16 avg | 9,704 | $593K | 100% |
| Filing → |
| AGIO | SELL | 2017-10-18 | $142K | — | Filing → |
| AGIO | SELL | 2017-09-15 | $131K | — | Filing → |
| AGIO | SELL | 2017-08-24 | $114K | — | Filing → |